Amlodipine Besylate Tablet
Product Images NDC 83008-035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 83008-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (1)

Image Description (1)
Label for Amlodipine Besylate Tablets USP 5 mg, supplied in a bottle of 30 tablets. The label includes storage instructions (68 to 77 degrees F), manufacturer details (Unichem Laboratories Ltd., India), and distributor Quality Care Products, LLC. The NDC on the label is 83008-035-30.*
FDA Label Image

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)
Chemical structure of Amlodipine Besylate, showing the molecular arrangement with various functional groups including a chlorine-substituted benzene ring and amine-containing side chain, consistent with the active ingredient in this product.*
FDA Label Image

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
A Kaplan-Meier curve showing event rates over time in months for two groups: Amlodipine and Placebo. The graph plots cumulative event rates with data points for number at risk over 24 months. The graph includes statistical data such as P-value, hazard ratio, and 95% confidence interval.*
FDA Label Image

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
A horizontal forest plot chart depicting hazard ratios with 95% confidence intervals comparing outcomes favoring Amlodipine versus placebo across various patient subgroups, including overall population, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis ranges from 0.0 to 2.0 hazard ratio with a central line at 1.0.*
FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 04)

FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.